about
Network-based inference framework for identifying cancer genes from gene expression dataDetection and clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with advanced non-small cell lung cancer.Post-trial access to treatment for patients participating in clinical trialsTyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancerTanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer.Modes of Cell Death Induced by Photodynamic Therapy Using Zinc Phthalocyanine in Lung Cancer Cells Grown as a Monolayer and Three-Dimensional Multicellular Spheroids.Erlotinib resistance in lung cancer: current progress and future perspectives.Basigin-2 upregulated by receptor activator of NF-κB ligand enhances lung cancer-induced osteolytic lesions.Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancerCancer stem cells in lung cancer: Evidence and controversies.Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis.Next-generation sequencing for lung cancer.Targeting roles of inflammatory microenvironment in lung cancer and metastasis.Pingyangmycin and Bleomycin Share the Same Cytotoxicity Pathway.ALK rearrangement in specific subtypes of lung adenocarcinoma: immunophenotypic and morphological features.Inflammation-induced radioresistance is mediated by ROS-dependent inactivation of protein phosphatase 1 in non-small cell lung cancer cells.Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells.Epidermal Growth Factor Signaling towards Proliferation: Modeling and Logic Inference Using Forward and Backward Search.Targeting signaling pathways in lung cancer therapy.MutScan: fast detection and visualization of target mutations by scanning FASTQ data.[Molecular pathology of the lungs. New perspectives by next generation sequencing].CRISPR therapeutic tools for complex genetic disorders and cancer (Review).
P2860
Q30670472-11325BCD-43B0-4691-ADAC-CC7557FB5A44Q34589493-66B2FC2C-01D1-4F16-A999-0BC30AC71814Q35382420-A8CBE2DD-2916-4EEA-800E-8538702C58F4Q36022297-920F3927-6714-4D89-8D2E-2203423AB3B7Q36299594-756E7B29-FC56-4675-81BC-04CC70D8001EQ36372998-887E224B-7FB6-4E37-81CC-295C43427908Q36605522-FB4FC914-7837-4C9E-8C0F-3283896C4E84Q36759878-9B8E4324-2BB2-4C10-850D-5FEDEF1AB684Q37670436-4FB252D5-33F2-4894-8F64-D43EDDAEDEA0Q37709551-E64ED7CB-0F08-4956-BC8B-6B29A2C0D1C3Q38107464-53A6F180-0124-42D4-9287-B0CF7E829E47Q38131798-355E3E03-65B1-49FD-879D-7C5E0F7A4354Q38522515-FF03FC74-4C6B-40EE-A219-4FBA7DC33C50Q38759996-323CD4AB-3376-4F8F-8399-3F52158379F3Q38863719-9FC08667-D818-4AD8-9BED-E9C294DC436CQ38868582-5471F75E-9E4B-470E-92E9-5A8E29061423Q38904614-84337261-75D0-4267-AC6A-6FEB7FA2FBFAQ42177923-0C3668E8-A04E-4155-9187-925BC5396CF2Q46006150-0D4A6B56-DB99-412D-B8FC-6C5F54E75E87Q47557931-8C91EE39-B8AD-47E5-9146-D7FB3B732991Q54048311-7E14DB24-4F41-4C85-8E00-405A6C5255A7Q55383943-AC82B4EC-AE65-4108-8FD7-087382F295EB
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Personalized targeted therapy for lung cancer
@ast
Personalized targeted therapy for lung cancer
@en
type
label
Personalized targeted therapy for lung cancer
@ast
Personalized targeted therapy for lung cancer
@en
prefLabel
Personalized targeted therapy for lung cancer
@ast
Personalized targeted therapy for lung cancer
@en
P2093
P2860
P921
P356
P1476
Personalized targeted therapy for lung cancer
@en
P2093
Larry House
William C S Cho
P2860
P304
11471-11496
P356
10.3390/IJMS130911471
P407
P50
P5008
P577
2012-09-13T00:00:00Z